Sonnet BioTherapeutics Holdings, Inc. (SONN) Dividend History

Sonnet BioTherapeutics Holdings, Inc. is a biotechnology company focused on developing novel therapies based on its proprietary peptide platform. The company's mission is to create targeted, effective treatments for a range of diseases, including cancers and autoimmune disorders, by leveraging innovative peptide technology to enhance drug delivery and efficacy.

100 Overlook Center, Princeton, NJ, 08540
Phone: 609-375-2227
Website: https://www.sonnetbio.com

Dividend History

Sonnet BioTherapeutics Holdings, Inc. currently does not pay dividends

Company News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SONN, FCCO, MGRM on Behalf of Shareholders

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for three companies: Sonnet BioTherapeutics, First Community Corporation, and Monogram Technologies, related to their recent merger or sale transactions.

GlobeNewswire Inc.

Featured Companies: FCCO MGRM
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: SONN, SKX, FCCO, and SGBG

Law firm Monteverde & Associates is investigating potential legal actions related to merger transactions involving Sonnet BioTherapeutics, Skechers, First Community Corporation, and Signature Bank of Georgia.

Benzinga

Featured Companies: FCCO SKX
Sonnet (SONN) Up as Ovarian Cancer Drug Enters Clinical Study

Sonnet (SONN) receives FDA clearance to begin clinical development for its combination therapy of SON-1010 and Roche's atezolizumab, for the potential treatment of platinum-resistant ovarian cancer.

Zacks Investment Research

Featured Companies: CORT EBS
Best Penny Stocks to Buy Under $1? 7 To Watch Now

Hot penny stocks to buy under $1 The post Best Penny Stocks to Buy Under $1? 7 To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: SIDU

Page data last updated 07/23/2025 16:25:44 UTC